11 Results for "

H460 NSCLC cells

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "H460 NSCLC cells" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P11143A
Research Areas:  

Cancer

IL4RPep-1 acetate is an interleukin-4 receptor (IL-4R) binding agent. IL4RPep-1 acetate preferentially binds to cells with high levels of IL-4R expression compared to those with low levels of expression. IL4RPep-1 acetate-labeled liposomes containing Doxorubicin (HY-15142A) are internalized by cells more efficiently. IL4RPep-1 acetate-labeled liposomes accumulate more effectively within H226 tumors .
loading...
    loading...
Cat. No.: HY-17026A
CAS No.: 110988-86-8
Synonyms: dFdCTP
Gemcitabine triphosphate (dFdCTP) is the active metabolite of Gemcitabine (HY-17026). The mechanism of Gemcitabine triphosphate cell-killing is its competition with cytidine triphosphate during DNA replication, which results in the inhibition of chain elongation. Gemcitabine triphosphate shows a Ki of 11.2 μM against DNA polymerase α and 14.4 μM against DNA polymerase ε. Gemcitabine triphosphate partially inhibits dCMP deaminase and acts as a substrate for DNA synthesis to incorporate into cellular DNA and RNA. Gemcitabine triphosphate disrupts DNA and RNA synthesis, arrests cell cycle in G0/G1 and S phases, triggers apoptosis, reduces tumor cell proliferation. Gemcitabine triphosphate can be used for the research of pancreatic cancer and non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-162753
CAS No.: 2351940-23-1
Target:  

P-glycoprotein

Research Areas:  

Cancer

ZW-1226 is a dual Tyrosyl DNA phosphodiesterase 2 (TDP2) and Multidrug resistance-associated protein 1 (MRP1) inhibitor with IC50 values of 0.2 and 0.5 μM, respectively. ZW-1226 exhibits selectivity over other ABC transporters. ZW-1226 elevates intracellular GSH levels, and reverses MRP1-mediated drug resistance. ZW-1226 can be used for the research of leukemia, non-small-cell lung cancer, and multidrug resistant small-cell lung cancer .
loading...
    loading...
Cat. No.: HY-157564
CAS No.: 2922110-00-5
Target:  

Apoptosis

Research Areas:  

Cancer

Antitumor agent-135 (Compound 13) is a potent antitumor agent. Antitumor agent-135 induces cell apoptosis, with IC50s of 3.79 , 10.55, 1.14, and 4.14 μM for NSCLC cell lines (A549, H460, PC-9, and PC-9/GR) .
loading...
    loading...
Cat. No.: HY-162896
CAS No.: 3029132-46-2
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

And1 degrader 1 (Compound A15) is a degrader of the acidic nucleoplasmic DNA-binding protein 1 (And1), which can significantly induce the degradation of And1 in NSCLC cells. And1 degrader 1 (5 μM) combined with Olaparib (HY-10162) (1 μM) effectively inhibits the proliferation of A549 and H460 cells. And1 degrader 1 can be used in cancer research .
loading...
    loading...
Cat. No.: HY-180562
CAS No.: 2579083-99-9
Target:  

Ras

Research Areas:  

Cancer

KARS-IN-1 (152) is a AKR1C3 dependent KARS inhibitor with an AC50 of 9.1 nM for human KARS. KARS-IN-1 shows anti-proliferative activity in H460 (NRF2 pathway mutant cell line with high AKR1C3 expression) and Hara (NRF2 pathway wild type cell line with low AKR1C3 expression), with AC50 values ??of 21 nM and 16 nM, respectively. KARS-IN-1 can be used for the study of non-small cell lung cancer (NSCLC) .
loading...
    loading...
Cat. No.: HY-150571
CAS No.: 2448091-11-8
Research Areas:  

Cancer

Anticancer agent 76 (Compound CT2-3) is an anticancer agent. Anticancer agent 76 significantly inhibits the proliferation of human NSCLC cells, induces cell cycle arrest, causes ROS generation and induces cell apoptosis .
loading...
    loading...
Cat. No.: HY-P11143
CAS No.: 1900734-29-3
Research Areas:  

Cancer

IL4RPep-1 is an interleukin-4 receptor (IL-4R) binding agent. IL4RPep-1 preferentially binds to cells with high levels of IL-4R expression compared to those with low levels of expression. IL4RPep-1-labeled liposomes containing Doxorubicin (HY-15142A) are internalized by cells more efficiently. IL4RPep-1-labeled liposomes accumulate more effectively within H226 tumors .
loading...
    loading...
Cat. No.: HY-181890
CAS No.: 3080792-24-8
Target:  

Glutaminase

Research Areas:  

Cancer

TRG-192 is a potent and selective glutaminase (GLS) inhibitor with an IC50 of 68 nM. TRG-192 inhibits intracellular glutamate levels. TRG-192 is applicable to related research on non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-171171
CAS No.: 2649242-85-1
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

NERx 329 is a replication protein A (RPA) inhibitor with an IC50 of 4.9 μM. NERx 329 blocks the interaction between RPA and single-stranded DNA, and induces functional RPA depletion, loss of single-stranded DNA gap protection, chromosome fragmentation and cell death. NERx 329 inhibits the DNA damage response signaling pathway, exhibits broad single-agent anticancer activity, and enhances the activity of DNA-damaging agents. NERx 329 can be used in research related to brca1-deficient breast cancer, non-small cell lung cancer, and brca1-deficient ovarian cancer .
loading...
    loading...
Cat. No.: HY-184300
Target:  

PD-1/PD-L1

Research Areas:  

Inflammation/Immunology Cancer

PDL1 degrader-4 is a PD-L1 degrader that induces PD-L1 degradation via the LAMP2-mediated lysosomal pathway, with a Kd value of 5.58 μM. PDL1 degrader-4 induces anti-tumor immunity through PD-L1 degradation. PDL1 degrader-4 is applicable to research related to non-small cell lung cancer .
loading...
    loading...
  • 1